Evaluating the Impact of Emergency Maternity Housing
Launched by UNIVERSITY OF NOTRE DAME · Jun 17, 2022
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how emergency maternity housing can help pregnant women who are facing housing problems. If a mom is interested in participating, she can call the agency to see if she meets the basic requirements. To qualify, she needs to be at least 18 years old, pregnant, and experiencing housing instability. Different homes may have specific rules, such as whether other children can stay with her or if a background check is needed.
Once a mom is determined to be eligible, she will fill out an application and may be placed on a waitlist. When a spot opens up, two moms at the top of the list will be interviewed to confirm their eligibility, and one will be randomly chosen to receive housing support while the other will continue without it. Both moms will be surveyed about a year after their baby's due date to understand the impact of the housing support. This trial is currently looking for participants, so if you or someone you know might be interested, it’s a good opportunity to get help during a challenging time.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Each home has their own eligibility criteria. The main three criteria common across homes are that a woman must be at least 18 years old, experiencing housing instability, and pregnant. No home has an income standard because, by definition, applicants are in a precarious housing situation so most women are low-income. Each home does have slightly different eligibility criteria. For example, some homes allow other children to come with her into the home, while other homes do not. Some homes require a background check and might allow a woman to enter the home anyway depending on the prior offense.
- Exclusion Criteria:
- • Women who are not pregnant, men, pregnant women under 18, some homes exclude mothers who have other children currently in their care
About University Of Notre Dame
The University of Notre Dame is a prestigious research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. Committed to excellence in research and education, the university leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies that address pressing medical challenges. With a focus on ethical practices and participant safety, the University of Notre Dame collaborates with healthcare professionals and community partners to translate scientific discoveries into effective therapies, ultimately enhancing patient care and contributing to the broader field of medical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Notre Dame, Indiana, United States
Patients applied
Trial Officials
William Evans, PhD
Principal Investigator
University of Notre Dame
Adrienne Sabety, PhD
Principal Investigator
University of Notre Dame
Jessica Brown, PhD
Principal Investigator
University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials